
IpiNovyx Bio
Developing multiple series of highly selective, ultra potent small molecule therapeutics for the treatment of autoimmune and inflammatory disorders.
Employees
Enterprise value
$40—60m
Authorizing premium user...
Developing multiple series of highly selective, ultra potent small molecule therapeutics for the treatment of autoimmune and inflammatory disorders.